Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study

BACKGROUND: More than half of Chinese patients with hormone receptor positive (HR+) ductal carcinoma in situ (DCIS) are treated with mastectomy, and usually subjected to postoperative endocrine therapy (ET). Given that long-term ET can cause severe adverse effects it is important to determine the be...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Nan, Zhang, Yinan, Bai, Yang, Wang, Xin, Yan, Shunchao, Song, Dong, Xu, Hong, Liu, Tong, Hua, Bin, Zhang, Yingchao, Liu, Jinchi, Qiao, Xinbo, Liu, Jiaxiang, Zheng, Xinyu, Cao, Hongyi, Liu, Caigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901931/
https://www.ncbi.nlm.nih.gov/pubmed/36745010
http://dx.doi.org/10.7554/eLife.83045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901931/
https://www.ncbi.nlm.nih.gov/pubmed/36745010
http://dx.doi.org/10.7554/eLife.83045

Ejemplares similares